STAT+: Pharmalittle: Merck suddenly finds Ebola vaccine doses in its freezers; drugs studied to combat women’s midlife mood swings
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of phone calls, online meetings, and deadlines has predictably returned. But what can you do? The world, such as it is, keeps spinning. So time to give it a nudge in a useful direction with a cup or three of stimulation. Our choice today is caramel apple. As always, please feel free to join us. Meanwhile, here is a menu of tidbits to help you get going. We hope your journey today is meaningful and productive. And of course, do stay in touch. We appreciate juicy tips and hearing about saucy doings. …
Researchers are testing several new drugs to treat depression and anxiety symptoms that women often experience during perimenopause, the years leading up to menopause, The Wall Street Journal tells us. Up to one-third of women experience depressive symptoms during this time, and antidepressants are often prescribed to women for midlife depression, but the drugs do not work for everyone and can have side effects. Now scientists are studying medications that may help combat perimenopausal mood changes in different ways. Some drugs are already approved for other health issues. Doctors are also hopeful some new drugs aimed at treating hot flashes may help with mood changes.
Continue to STAT+ to read the full story…
